Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01836354 · ClinicalTrials.gov registry record · NA
Discharge Educational Strategies for Reduction of Vascular Events
A NA study of Ischemic Stroke and Hemorrhagic Strokes, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 552
- Enrollment target
- 3
- Study locations
NCT01836354: Completed NA study of Ischemic Stroke and Hemorrhagic Strokes, sponsored by NYU Langone Health.
NCT01836354 is a NA study of Ischemic Stroke and Hemorrhagic Strokes that has completed, run by NYU Langone Health. The registered enrollment target is 552 participants, below the 1,455-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (62% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01836354, a NA study of Ischemic Stroke and Hemorrhagic Strokes, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 552 participants
- Enrollment target
- 3
- Study locations
Study Summary
DESERVE is a discharge education study using health workers to enroll and randomly assign 800 subjects diagnosed with TIA, or mild stroke to either risk factor education or usual care. Those patients assigned to education will receive stroke preparedness education plus risk factor reduction education, and help accessing follow up care with health workers. Those patients assigned to usual care will receive written stroke preparedness education. This protocol will evaluate the effectiveness of this intervention to reduce blood pressure, and individual stroke risk factors and future stroke risk.
Primary Outcome
change in overall blood pressure
Conditions Studied
Interventions
- BEHAVIORAL DESERVE education
Study Locations (3)
New York
- NYU Langone Medical Center - New York
- Icahn School of Medicine at Mount Sinai - New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 552 participants |
| Start Date | 2012-08 |
| Est. Completion | 2019-11 |
| Phase | NA |
What the finished NCT01836354 record still lists
NCT01836354 is an interventional study that assigns participants to a tested intervention. The registered 552 participants enrollment target is mid-sized for trials with a published cap, below the 1,455-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (62% lower).
The record links to 4 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which DESERVE education is the first listed.
NCT01836354 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01836354 about?
NCT01836354 is a clinical study titled "Discharge Educational Strategies for Reduction of Vascular Events". DESERVE is a discharge education study using health workers to enroll and randomly assign 800 subjects diagnosed with TIA, or mild stroke to either risk factor education or usual care. Those patients assigned to education will receive stroke preparedness education plus risk factor reduction educatio...
What is the current status of trial NCT01836354?
This trial is currently completed. It is a NA study. The enrollment target is 552 participants. The study started on 2012-08. Estimated completion is 2019-11.
What conditions does trial NCT01836354 study?
This clinical trial studies the following conditions: Ischemic Stroke, Hemorrhagic Strokes, Intracerebral Infarcts, TIA's.
What interventions are being tested in trial NCT01836354?
The interventions under investigation include: DESERVE education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01836354?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01836354 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01836354's enrollment target sits among peer trials
552 15th of 66 higher than 52 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
StrokeNet Thrombectomy Endovascular Platform
RECRUITING · NA
-
Virtual Reality Based Rehabilitation After Ischemic Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06217809 · 552 participants · NA
EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.
- NCT07146022 · 552 participants · Phase 3
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- NCT05786924 · 554 participants · Phase 1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia